Paper41008623
The Role of Reactive Oxygen Species in Lung Cancer Development: Nanomedicine as a Therapeutic Strategy.
Olazábal-Morán M and 3 others. Biomolecules, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The Role of Reactive Oxygen Species in Lung Cancer Development: Nanomedicine as a Therapeutic Strategy. Papers, record 41008623. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008623
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Role of Reactive Oxygen Species in Lung Cancer Development: Nanomedicine as a Therapeutic Strategy.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Reactive Oxygen Species | Major topic |
| Lung Neoplasms | Major topic |
| Nanomedicine | Major topic |
| Humans | |
| Animals | |
| NF-E2-Related Factor 2 | |
| Antineoplastic Agents | |
| Signal Transduction |
Source PubMed
References195
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35146935 | Recent Advances in Dual BRD4-Kinase Inhibitors Based on Polypharmacology. | ChemMedChem | 2022 | https://conductscience.org/library/papers/35146935 | PubMed |
| 2 | 35096502 | A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents. | Bionanoscience | 2022 | https://conductscience.org/library/papers/35096502 | PubMed |
| 3 | 39232287 | Emerging methods and techniques for cancer biomarker discovery. | Pathol Res Pract | 2024 | https://conductscience.org/library/papers/39232287 | PubMed |
| 4 | 27020858 | NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth. | Cancer Res | 2016 | https://conductscience.org/library/papers/27020858 | PubMed |
| 5 | 17149983 | Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. | Radiat Res | 2006 | https://conductscience.org/library/papers/17149983 | PubMed |
| 6 | 31115493 | Mitochondrial electron transport chain, ROS generation and uncoupling (Review). | Int J Mol Med | 2019 | https://conductscience.org/library/papers/31115493 | PubMed |
| 7 | 34426760 | Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34426760 | PubMed |
| 8 | 31276347 | Squamous cell lung cancer: genomic evolution and personalized therapy. | Salud Publica Mex | 2019 | https://conductscience.org/library/papers/31276347 | PubMed |
| 9 | 32510788 | Mutant-Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug-Resistant Mutations. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/32510788 | PubMed |
| 10 | 36170674 | Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/36170674 | PubMed |
| 11 | 27606290 | Lung cancer in the Indian subcontinent. | South Asian J Cancer | 2016 | https://conductscience.org/library/papers/27606290 | PubMed |
| 12 | 31989830 | Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. | Antioxid Redox Signal | 2020 | https://conductscience.org/library/papers/31989830 | PubMed |
| 13 | 36750097 | Piperlongumine conjugates induce targeted protein degradation. | Cell Chem Biol | 2023 | https://conductscience.org/library/papers/36750097 | PubMed |
| 14 | 22286106 | Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. | Cell Signal | 2012 | https://conductscience.org/library/papers/22286106 | PubMed |
| 15 | 35469399 | Designing Soluble PROTACs: Strategies and Preliminary Guidelines. | J Med Chem | 2022 | https://conductscience.org/library/papers/35469399 | PubMed |
| 16 | 26637667 | Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer. | Cancer Res | 2016 | https://conductscience.org/library/papers/26637667 | PubMed |
| 17 | 29282291 | Regulation of redox balance in cancer and T cells. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29282291 | PubMed |
| 18 | 30542529 | Targeting Brd4 for cancer therapy: inhibitors and degraders. | Medchemcomm | 2018 | https://conductscience.org/library/papers/30542529 | PubMed |
| 19 | 27746276 | Design and fabrication of hydrogel-based nanoparticulate systems for in vivo drug delivery. | J Control Release | 2016 | https://conductscience.org/library/papers/27746276 | PubMed |
| 20 | 32616502 | The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer. | Cancer Res | 2020 | https://conductscience.org/library/papers/32616502 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42449418 | Progressive elevation of MnSOD and GPX4 expression across the spectrum of pulmonary adenocarcinoma lesions: a digital pathology study. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42449418 | PubMed |
| 42397646 | Targeted nanomedicine strategies for Alzheimer's disease therapy. | Discov Nano | 2026 | https://conductscience.org/library/papers/42397646 | PubMed |
| 42245248 | Airborne metals and malignant pleural effusions: the role of oxidative stress. | Front Toxicol | 2026 | https://conductscience.org/library/papers/42245248 | PubMed |
| 41516132 | Intratumoral Microbiota in Lung Cancer: Emerging Roles in TME Modulation and Immunotherapy Response. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516132 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008623
GET https://conductscience.org/api/papers/v1/41008623/references?page=2